Why did AFME.PA stock spike today?

AFME.PA stock spiked due to heavy trading liquidity: **248,488.00** shares versus an average **27,900.00**. High relative volume **6.64** often follows news, block trades or retail interest. Confirm any catalyst from company statements before trading.

What valuation concerns exist for AFME.PA stock?

Valuation flags: EPS **-0.36**, price-to-sales **23.52**, price-to-book **5.24**, and debt-to-equity **1.11**. These metrics reflect a loss-making device firm with high multiples versus Healthcare peers.

What targets and risks should traders use for AFME.PA stock?

Intraday target **€4.50** (resistance), medium model target **€2.27**. Initial support **€3.46** and tighter stop-loss below **€3.00** recommended. Major risks include operating losses and receivables days **325.12**.

How should investors interpret Meyka AI forecasts for AFME.PA stock?

Meyka AI's forecast model projects quarterly **€2.27** and yearly **€1.56**. These are model-based projections implying downside versus current **€3.70**. Forecasts are informational, not guarantees; combine with fundamental checks.

EU Stocks

AFME.PA Affluent Medical EURONEXT 10 Feb 2026: €3.70 on heavy volume, watch

ByHuzaifa Zahoor February 10, 2026

AFME.PA stock surged intraday to €3.70, a +31.67% move on a volume spike of 248,488 shares on EURONEXT (Europe). The stock opened at €3.70, hit a day high of €4.34 and traded well above its 50-day average of €1.78, signaling a large liquidity event. Traders noted a relative volume of 6.64, with average daily volume at 27,900 shares. We run through technicals, fundamentals, Meyka AI grading and short-term price guidance for high-volume movers.